Gates Frontier

Funding rounds backed by Gates Frontier.

Export CSV
Funding disclosed in full
$630M
Median round
$257M
Rounds in calculation
3
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series EBiotechUnited States
9 participantsARCH Venture PartnersBezos ExpeditionsGates FrontierGSKGV (Google Ventures)InvusLoLa Capital PartnersMilky Way InvestmentsRA Capital Management
Cellares

Develops automated cell therapy manufacturing platforms

$257MSeries DBiotechUnited States
11 participantsBaillie GiffordBlackRockDC Global VenturesDFJ GrowthDuquesne Family OfficeEclipseEDBIGates FrontierIntuitive VenturesT. Rowe Price Investment ManagementWillett Advisors
Neurophos

Develops photonic AI inference chips for data centers

$110MSeries AAIUnited States
16 participantsAlumni VenturesAramco VenturesBosch VenturesCarbon Direct CapitalDNX VenturesGaingelsGates FrontierGeometryM12 (Microsoft's Venture Fund)Mana VenturesMetaVC PartnersMorgan Creek CapitalSilicon Catalyst VenturesSpace CapitalTectonic VenturesWonderstone Ventures